Latina breast cancer patients provided with information about clinical trials in multiple ways, including a culturally sensitive, computer-based video on breast cancer clinical trials, had much greater awareness of clinical trials compared with patients who received usual-care information, according to data presented at the American Association for Cancer Research (AACR) conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Nov. 9–12.
After receiving the additional information, the proportion of Latina breast cancer patients taking steps toward participating in a clinical trial increased from 38 percent to 75 percent.
"Latinos represent 17 percent of the U.S. population but only 5.6 percent of participants in National Cancer Institute treatment clinical trials," said Patricia Chalela, DrPH, assistant professor of epidemiology and biostatistics at the Institute for Health Promotion Research (IHPR) at The University of Texas Health Science Center at San Antonio. "Underrepresentation of minorities in clinical trials results in disparities of cancer outcomes and limits generalizability of the findings because researchers cannot study how minority patients respond to new treatments.
"Our results showed that intervention participants had significantly higher awareness of clinical trials than control participants," continued Chalela, who is part of the study team led by Amelie G. Ramirez, DrPH, director of the IHPR. "We hope that computer-based videos specifically tailored for Latinos will provide an effective strategy to increase Latina breast cancer patients' knowledge, understanding, and participation in clinical trials, although this needs confirming in larger studies."
The study is in its last year of recruitment. To date, Chalela, Ramirez, and colleagues have enrolled 71 Latina breast cancer patients eligible to participate in a breast cancer clinical trial at the Cancer Therapy and Research Center at the UT Health Science Center San Antonio. Participants are randomly assigned to usual-care clinical trial information or additional information, which is provided through viewing of a culturally sensitive, computer-based video about breast cancer clinical trials, reading a tailored booklet on the topic, and receiving assistance from a patient navigator.
When compared with patients assigned to usual-care clinical trial information, patients assigned to additional information had significantly higher awareness of clinical trials, in particular, the purpose of clinical trials, the requirements for enrollment, the benefits and risks of clinical trials, and the potential of clinical trials as an appropriate treatment for a serious disease.
"These results are encouraging," Chalela said. "We would like to assess the intervention at a larger scale and make the intervention available not only to all breast cancer patients, but expand it to all cancer patients in general."
Explore further: A call to arms in cancer research
Medical Xpress on facebook
Related Stories
A call to arms in cancer research
May 19, 2014
Hispanics are the fastest-growing demographic group in the United States, and they suffer from major health disparities, including higher rates of cancers of the cervix, stomach and liver.
Roche breast cancer drug 'helps patients live longer': study
Sep 29, 2014
A drug developed by Swiss giant Roche to treat an aggressive form of breast cancer has been shown to extend patients' lives by almost 16 months, researchers said Sunday.
Black patients received less clinical trial information than white patients
Oct 29, 2012
A study comparing how physicians discuss clinical trials during clinical interactions with black patients versus white patients further confirms racial disparities in the quality of communication between physicians and patients.
Study measures breast cancer tumor response to neoadjuvant chemotherapy
Oct 23, 2014
A Dartmouth study suggests that it may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast cancer tumors ...
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant
Dec 12, 2013
Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery treatment with chemotherapy and HER2-targeted therapies if their cancer had one or more ...
Recommended for you
Researchers find promising therapeutic target for deadliest brain cancer
55 seconds ago
(Medical Xpress)—A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer cells that is not present in healthy brain cells, making the enzyme a promising therapeutic ...
Building proteins to counteract cancer
40 minutes ago
Karmella Haynes wants to help the body fight cancer by designing proteins to stop the disease.
Tumor-associated neutrophils boost anti-tumor immune responses
4 hours ago
Lung cancer is a leading cause of cancer-related deaths in both men and women, and survival depends on the stage of cancer at diagnosis. An inflammatory response is induced following tumor formation, and the immune cells ...
Medicare proposes covering lung cancer screening
12 hours ago
Medicare may soon begin paying for scans to detect lung cancer in certain current or former heavy smokers.
Lung cancer screening with low-dose CT could be cost effective
12 hours ago
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This r ...
Smoking associated with elevated risk of developing a second smoking-related cancer
12 hours ago
Results of a federally-funded pooled analysis of five prospective cohort studies indicate that cigarette smoking prior to the first diagnosis of lung (stage I), bladder, kidney or head and neck cancer increases risk of developing ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
Latina breast cancer patients provided with information about clinical trials in multiple ways, including a culturally sensitive, computer-based video on breast cancer clinical trials, had much greater awareness of clinical trials compared with patients who received usual-care information, according to data presented at the American Association for Cancer Research (AACR) conference on The Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Nov. 9–12.
After receiving the additional information, the proportion of Latina breast cancer patients taking steps toward participating in a clinical trial increased from 38 percent to 75 percent.
"Latinos represent 17 percent of the U.S. population but only 5.6 percent of participants in National Cancer Institute treatment clinical trials," said Patricia Chalela, DrPH, assistant professor of epidemiology and biostatistics at the Institute for Health Promotion Research (IHPR) at The University of Texas Health Science Center at San Antonio. "Underrepresentation of minorities in clinical trials results in disparities of cancer outcomes and limits generalizability of the findings because researchers cannot study how minority patients respond to new treatments.
"Our results showed that intervention participants had significantly higher awareness of clinical trials than control participants," continued Chalela, who is part of the study team led by Amelie G. Ramirez, DrPH, director of the IHPR. "We hope that computer-based videos specifically tailored for Latinos will provide an effective strategy to increase Latina breast cancer patients' knowledge, understanding, and participation in clinical trials, although this needs confirming in larger studies."
The study is in its last year of recruitment. To date, Chalela, Ramirez, and colleagues have enrolled 71 Latina breast cancer patients eligible to participate in a breast cancer clinical trial at the Cancer Therapy and Research Center at the UT Health Science Center San Antonio. Participants are randomly assigned to usual-care clinical trial information or additional information, which is provided through viewing of a culturally sensitive, computer-based video about breast cancer clinical trials, reading a tailored booklet on the topic, and receiving assistance from a patient navigator.
When compared with patients assigned to usual-care clinical trial information, patients assigned to additional information had significantly higher awareness of clinical trials, in particular, the purpose of clinical trials, the requirements for enrollment, the benefits and risks of clinical trials, and the potential of clinical trials as an appropriate treatment for a serious disease.
"These results are encouraging," Chalela said. "We would like to assess the intervention at a larger scale and make the intervention available not only to all breast cancer patients, but expand it to all cancer patients in general."
Explore further: A call to arms in cancer research
Medical Xpress on facebook
Related Stories
A call to arms in cancer research
May 19, 2014
Hispanics are the fastest-growing demographic group in the United States, and they suffer from major health disparities, including higher rates of cancers of the cervix, stomach and liver.
Roche breast cancer drug 'helps patients live longer': study
Sep 29, 2014
A drug developed by Swiss giant Roche to treat an aggressive form of breast cancer has been shown to extend patients' lives by almost 16 months, researchers said Sunday.
Black patients received less clinical trial information than white patients
Oct 29, 2012
A study comparing how physicians discuss clinical trials during clinical interactions with black patients versus white patients further confirms racial disparities in the quality of communication between physicians and patients.
Study measures breast cancer tumor response to neoadjuvant chemotherapy
Oct 23, 2014
A Dartmouth study suggests that it may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast cancer tumors ...
PIK3CA gene mutations make HER2- and hormone receptor-positive breast cancers treatment-resistant
Dec 12, 2013
Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery treatment with chemotherapy and HER2-targeted therapies if their cancer had one or more ...
Recommended for you
Researchers find promising therapeutic target for deadliest brain cancer
55 seconds ago
(Medical Xpress)—A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer cells that is not present in healthy brain cells, making the enzyme a promising therapeutic ...
Building proteins to counteract cancer
40 minutes ago
Karmella Haynes wants to help the body fight cancer by designing proteins to stop the disease.
Tumor-associated neutrophils boost anti-tumor immune responses
4 hours ago
Lung cancer is a leading cause of cancer-related deaths in both men and women, and survival depends on the stage of cancer at diagnosis. An inflammatory response is induced following tumor formation, and the immune cells ...
Medicare proposes covering lung cancer screening
12 hours ago
Medicare may soon begin paying for scans to detect lung cancer in certain current or former heavy smokers.
Lung cancer screening with low-dose CT could be cost effective
12 hours ago
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine. This r ...
Smoking associated with elevated risk of developing a second smoking-related cancer
12 hours ago
Results of a federally-funded pooled analysis of five prospective cohort studies indicate that cigarette smoking prior to the first diagnosis of lung (stage I), bladder, kidney or head and neck cancer increases risk of developing ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
Great post.
ReplyDeletehttps://treatmentplans.wixsite.com/mysite